Malafosse Michel
Hôpitaux de Paris.
Bull Acad Natl Med. 2003;187(1):103-14; discussion 114-6.
The purposes of this study are: 1) to evaluate if recent progresses (knowledge of natural history, genetic diagnosis and surgical treatment) have an impact upon the long term follow up of familial adenomatous polyposis (FAP); 2) to assess the prognosis factors that are relative to recent progresses in diagnosis and treatment procedures. A retrospective study of 51 cases was carried out in July 2002 to analyse the following characteristics: phenotype, treatment, operative mortality and morbidity, late complications, especially rectal stump cancer after ileo-rectal anastomosis, duodenal adenomatosis and desmoid tumors. Twenty seven men and 24 women underwent surgery: 11 colo-rectal cancers were present at first step. Initial surgical procedures included 39 total colectomies with ileo-rectal anastomosis (IRA), 6 coloproctectomies with ileo-anal anastomosis (IAA) and 6 coloproctectomies with permanent ileostomy. Operative mortality was nil. Operative morbidity affected 11 patients. The rectum had to be secondary removed in 11 patients with convert in IAA. Duodenal adenomatosis required surgery in 10 patients: 5 surgical local excisions, 4 duodenopancreatectomies and 1 palliative by-pass. Six desmoid tumors were noted during the follow-up. On the whole 3 patients were lost of sight. Nine patients died (19.1%), 4 deaths were in relation with the disease: 1 rectal cancer, 2 duodenal cancers, 1 desmoid tumor necrosis. At the end of the follow up (mean duration: 17 years) 26 IRA and 17 IAA are present with good functional results. This study, according to already published data, suggests that today the risk of death related to colorectal cancer is becoming lower than the risk of death from duodenal cancer and desmoid tumor evolution, particularly since the introduction of the restorative proctocolectomy. The genetic diagnosis is useful in order to determine the choice of surgical procedures.
1)评估近期进展(自然史知识、基因诊断和外科治疗)是否对家族性腺瘤性息肉病(FAP)的长期随访有影响;2)评估与诊断和治疗程序近期进展相关的预后因素。2002年7月对51例患者进行了回顾性研究,以分析以下特征:表型、治疗、手术死亡率和发病率、晚期并发症,尤其是回直肠吻合术后的直肠残端癌、十二指肠腺瘤病和硬纤维瘤。27名男性和24名女性接受了手术:第一步时有11例结直肠癌。初始手术程序包括39例全结肠切除术加回直肠吻合术(IRA)、6例结肠直肠切除术加回肠肛管吻合术(IAA)和6例结肠直肠切除术加永久性回肠造口术。手术死亡率为零。11例患者出现手术并发症。11例IAA转换患者中,有11例需要二次切除直肠。10例患者的十二指肠腺瘤病需要手术治疗:5例手术局部切除、4例十二指肠胰切除术和1例姑息性旁路手术。随访期间发现6例硬纤维瘤。总体而言,3例患者失访。9例患者死亡(19.1%),4例死亡与疾病相关:1例直肠癌、2例十二指肠癌、1例硬纤维瘤坏死。随访结束时(平均持续时间:17年),26例IRA和17例IAA功能良好。根据已发表的数据,本研究表明,如今与结直肠癌相关的死亡风险正低于十二指肠癌和硬纤维瘤进展导致的死亡风险,特别是自恢复性直肠结肠切除术引入以来。基因诊断有助于确定手术程序的选择。